Loading
journalsJournal
JCO Oncology Practice
ASCO's journal about how cancer care is actually delivered and paid for: financial toxicity, workforce, quality measures, telehealth and payment reform.
Also called: JCO OPJournal of Oncology PracticeJOP
Overview
JCO Oncology Practice was formerly Journal of Oncology Practice (renamed 2020). It publishes health-services research, quality-improvement studies, cost and financial-toxicity analyses, and policy pieces on the US oncology payment system. The main outlet for evidence on care-delivery bottlenecks rather than on drugs themselves.
Publisher
American Society of Clinical Oncology · American Society of Clinical Oncology
Scope
oncology practice and policy
Website
Access model
hybrid
Founded
2005
ISSN
2688-1527
rct20260 citations
Participant-Reported Preference for Pembrolizumab Administered Subcutaneously or Intravenously: A Randomized, Open-Label, Phase II Study
This is the paper Europe PMC returns for registry id NCT06099782 with the most citations, so it is the natural first reading for anyone following the trial. Read the abstract above alongside the trial page and the registry entry; the record was linked automatically and its figures have not been checked by hand.
review2021113 citations
Telehealth in Oncology: ASCO Standards and Practice Recommendations
Two technology pages on OnCo cite this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing pages listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
observational2014195 citations
Projected supply of and demand for oncologists and radiation oncologists through 2025: an aging, better-insured population will result in shortage
One bottleneck page and 15 idea pages on OnCo cite this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing pages listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
Claudio Lombardo
OECI General Manager
Cancer centre networksHealth policyAccreditation and designation
Long-serving General Manager of the OECI, running the day-to-day operations of Europe's cancer institute network.
Derrick S. Haslem
Senior Medical Director of the Oncology Clinical Program, Intermountain Health
Medical oncologyBreast cancerCancer genomics and targeted therapy
Medical oncologist who leads the oncology clinical programme across Intermountain Health's cancer centres in Utah and neighbouring states.
Monika Krzyzanowska
Chief, Odette Cancer Program, Sunnybrook Health Sciences Centre
Medical oncologyHealth services researchQuality of cancer care
Medical oncologist and health services researcher who leads the Odette Cancer Program at Sunnybrook in Toronto, one of Canada's largest cancer centres.
Robin T. Zon
ASCO President 2024-2025; Medical Oncologist, Michiana Hematology Oncology
Community oncologyClinical trial accessHealth policy
Community oncologist who led ASCO in 2024-25 with a focus on bringing trials to patients close to home.
rctJCO Oncology Practice 20260 citations
Participant-Reported Preference for Pembrolizumab Administered Subcutaneously or Intravenously: A Randomized, Open-Label, Phase II Study
This is the paper Europe PMC returns for registry id NCT06099782 with the most citations, so it is the natural first reading for anyone following the trial. Read the abstract above alongside the trial page and the registry entry; the record was linked automatically and its figures have not been checked by hand.
reviewJCO Oncology Practice 2021113 citations
Telehealth in Oncology: ASCO Standards and Practice Recommendations
Two technology pages on OnCo cite this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing pages listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
observationalJCO Oncology Practice 2014195 citations
Projected supply of and demand for oncologists and radiation oncologists through 2025: an aging, better-insured population will result in shortage
One bottleneck page and 15 idea pages on OnCo cite this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing pages listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
institutions
terms
people
key papers
Participant-Reported Preference for Pembrolizumab Administered Subcutaneously or Intravenously: A Randomized, Open-Label, Phase II StudyProjected supply of and demand for oncologists and radiation oncologists through 2025: an aging, better-insured population will result in shortageTelehealth in Oncology: ASCO Standards and Practice Recommendations